AI Power for Future Growth: Insilico Leadership Team to Speak at FII 2025 (IMAGE)
Caption
To illustrate how generative AI breakthrough is driving real-world healthcare solutions, Alex Zhavoronkov PhD, founder and CEO of Insilico Medicine, will be speaking about the topic “Can Cell-Based lnnovation Keep Humanity in Peak Condition?” from 1:45 PM-2:10 PM local time, Oct 29. The next day, Alex Aliper, PhD, President of Insilico Medicine, will share the know-hows obtained in continued AI platform development and reproducible proof-of-concept achieved with highly efficient novel pipelines at Insilico, in the FII Innovators Pitch 2025 session.
Credit
Insilico Medicine & FII9
Usage Restrictions
None
License
Original content